Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 14, 2023; 29(22): 3519-3533
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3519
Figure 4
Figure 4 Comparison of the rebleeding-free rate between the patients with endoscopic therapy+non-selective β-blockers and covered transjugular intrahepatic portosystemic shunts. A: The total cohort; B: Patients on low-hepatic venous pressure gradient (HVPG) tier; C: Patients on high-HVPG tier; TIPS: Transjugular intrahepatic portosystemic shunt; NSBBs: Non-selective β-blockers.